Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
1003 participants
OBSERVATIONAL
2015-09-30
2019-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Korea National Diabetes Program
NCT01212198
Metabolic Syndrome and Prediabetes
NCT07243821
A Study to Evaluate Coronary Atherosclerosis in Patients With Diabetes Mellitus
NCT05801432
Prevalence of Subclinical Atherosclerosis and Its Associated Factors in Hyperlipidemic Korean Adults With Diabetes
NCT01264263
Association Between Mortality and Diabetes in Elderly Koreans: the South-West Seoul (SWS) Study
NCT01977391
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Normal cohort
Normal cohort for biobank
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Diabetic patients who are well controlled with oral antidiabetic agents
* Hypertensive patients who are well controlled with oral antihypertensive agents
* Dyslipidemic patients who are well controlled with oral lipid-lowering agents
Exclusion Criteria
* Chronic wasting disease
* Long-term steroid use
20 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Seoul National University Bundang Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Soo Lim
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Soo Lim, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
SNUBH
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Seoul National University Bundang Hospital
Seongnam-si, Gyeonggi-do, South Korea
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SNUBH-Biobank
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.